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SUMMARY – Tenosynovial giant cell tumor (TGCT) is a benign proliferative lesion of unclear etio-
logy. It is predominantly monoarticular and involves the synovium of the joint, tendon sheath, and 
bursa. TGCT of the temporomandibular joint (TMJ) is rare and aggressive resulting in destruction 
of surrounding structures. The diagnosis may be suggested by imaging, mainly by the MR features 
and PET/CT, and confirmed by histopathology. We describe the case of a 50-year-old man who 
presented with right-sided hearing loss, tinnitus and TMJ pain. Pathology revealed tenosynovial 
giant cell tumor with chondroid metaplasia. Six years later he developed a recurrence, which was 
documented to our knowledge for the first time with CT, MR and FDG PET/CT imaging.
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Introduction
Tenosynovial giant cell tumor (TGCT) is a 
benign proliferative lesion of unclear etiol-
ogy, which is predominantly monoarticular 
and involves the synovium of the joint, tendon 
sheath, and bursa. TGCT of the temporoman-
dibular joint (TMJ) is rare with only 58 cases 
having been reported. It may be clinically mis-
interpreted as a parotid mass, may involve the 
adjacent skull base, and may have variable ex-
tension to the temporal bone. 
We describe a case of TGCT arising from 
the temporomandibular articular capsule and 
extending into the temporal bone, with recur-
rence after six years. Histologically, the mass 
presented areas of classic TGCT with foci of 
chondroid metaplasia. The mass was com-
pletely documented with CT, MR and FDG 
PET/CT imaging, which to our knowledge is 
the first such case to be documented with all of 
these imaging modalities. 
Case Report
A 50-year-old man with a five-year history 
of right-sided hearing loss and TMJ pain pre-
sented with constant, non-pulsatile tinnitus. 
The otologic examination at presentation was 
unremarkable. Imaging studies revealed a de-
structive lesion in the right infratemporal fossa 
and glenoid fossa, extending into the overlying 
temporal bone. An ill-defined lytic mass within 
the right temporal bone was documented on CT 
(Figure 1A), with slightly enhancing soft tis-
sue components extending over the roof of the 
glenoid fossa without gross abnormality of the 
mandibular condyle. The margins of the lesion 
had a scalloped appearance. There was exten-
sion to the external auditory canal and erosion 
along both the anterior and posterior margins 
of the canal. This mass showed increased F18-
FDG uptake in the temporal bone (max SUV of 
6.4) and mildly increased FDG uptake in the 
soft tissue of the external auditory canal (max 
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Figure 1  A) Preoperative axial CT scan in bone algorithm shows an ill-defined lytic mass within the right temporal bone. B) Pr-
eoperative PET-CT with corresponding area of increased avidity for F18-FDG. C) Preoperative axial T2-weighted imaging reveals 
predominantly hypointense right temporal mass.
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Figure 2  A) Initial biopsy showing chondroid matrix with “chicken wire” calcification (arrow) resembling chondroblastoma. H&E, 
original magnification, ×20. B) Resection specimen showing conventional tenosynovial giant cell tumor with mononuclear histio-
cyte-like cells, scattered osteoclast-type giant cells and hemosiderin pigment. H&E, original magnification, ×20. C) Tenosynovial 
giant cell tumor with chondroid metaplasia showing  abundant hemosiderin pigment on the left side and chondroid area in the 
center. H&E, original magnification, ×10. D) Closer view of the interface between classic tenosynovial giant cell tumor and area 
of chondroid metaplasia. H&E, original magnification, ×20. E) Multinucleated giant cells and a subpopulation of the mononuclear 
cells are positive for CD68. CD68 immunostain, original magnification, ×20.
Figure 3  Immediate postoperative axial CT scan in bone algo-
rithm reveals a surgical bed with smooth bony margins.
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SUV of 3.5) (Figure 1B). On MR imaging the 
soft tissue mass presented a predominantly 
hypointense signal on T1- and T2-weighted im-
ages (Figure 1C). There was no significant ad-
enopathy in the neck region.
A biopsy was initially performed through a 
right preauricular incision, which exposed tu-
mor invading the cartilaginous portion of the 
external auditory canal and the superior and 
medial aspects of the glenoid fossa. The cap-
sule of the condyle was resected, where there 
was obvious destruction and tumor, as well as 
the nidus of the origin of the tumor. A tempo-
roparietal approach then allowed resection of 
the remaining temporal bone tumor. The ini-
tial biopsy revealed histological features simi-
lar to a chondroblastoma of bone, with “chicken 
wire” calcifications within a chondroid matrix 
(Figure 2A). Pathological examination of the 
resection specimen showed tumor involv-
ing synovium and bone with classic features 
of TGCT (Figure 2B), including mononuclear 
histiocyte-like cells, osteoclast-type giant cells, 
extensive hemosiderin deposition and areas of 
chondroid metaplasia (Figure 2C and/or 2D), 
focally resembling chondroblastoma. The tu-
mor cells were diffusely positive for CD68 and 
focally positive for S100 protein. The final di-
agnosis was tenosynovial giant cell tumor with 
chondroid metaplasia.
Postoperative CT and MR studies showed 
soft tissue material throughout the operative 
bed representing a flap and inflammatory op-
erative changes. Of note were smooth post sur-
gical bony margins (Figure 3). No suspected re-
sidual tumor was observed at that time. How-
ever, MR and CT imaging performed six years 
after the surgery again showed a lytic lesion 
with scalloped bony margins extending into the 
greater wing of the sphenoid bone associated 
with mildly enhancing soft tissue extending 
back into the mastoid and middle ear (Figure 
4A,B). These features were suspicious for re-
current tumor, confirmed on a new PET/CT, 
which showed a mass with increased 18-FDG 
uptake in the operative bed of the right tem-
poral bone (Figure 4C). Additionally there was 
a diffuse sclerotic reaction in the greater sphe-
noid wing and right mandibular condyle, and 
there was an enhanced soft tissue thickening 
around the lateral aspect of external auditory 
canal, compatible with postoperative changes. 
The suspected recurrence was biopsy proven 
and wide surgical removal was performed.
Discussion
Tenosynovial giant cell tumor (TGCT) is de-
fined by the World Health Organization as a 
locally aggressive neoplasm composed of syno-
vial-like mononuclear cells admixed with multi-
nucleate giant cells, foam cells, siderophages 
and inflammatory cells. It affects most com-
monly the knee and hip in young adults 1. In-
volvement of TMJ is rare. In the current lit-
erature there are 58 cases described with one 
third of them having intracranial involvement 
2. Some authors advocate that the majority of 
tumors affecting the TMJ are extraarticular, 
more infiltrative, extend to the temporal bone, 
and have higher recurrence rates 1,5. By defi-
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Figure 4  A) Axial CT scan in bone algorithm, of 6 years of follow-up, shows a lytic lesion with irregular, ill-defined bony margins. 
B) Follow-up MR with axial T2-weighted imaging hypointensity, not specific requiring correlation with PET avidity for F18-FDG. 
C) PET-CT shows increased F18-FDG avidity in the temporal portion of the surgical bed, reflecting recurrence.
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nition, the extraarticular form of TGCT con-
sists of an infiltrative soft tissue mass, with 
or without involvement of the adjacent joint 1. 
The macroscopic appearance is usually multin-
odular, instead of presenting the typical villous 
patterns seen in the intraarticular forms 1.
Skull base involvement and intracranial 
extension have been previously described 3-6 
as has a case presenting as a middle cranial 
fossa mass 7. The rare malignant form of TGCT 
with metastatic lesions in the lungs and lymph 
nodes has also been documented 8.
Recurrence is common, may be multiple, 
with 33-50% developing as the extraarticular 
form 1. As recurrences are associated with posi-
tive surgical margins, wide excision should be 
the treatment of choice 1,9. Cai et al. reported a 
recurrence rate of 11% for TGCT of the TMJ6. 
Genetic studies have revealed a translocation 
involving the genes CSF-1 on chromosome 1 
and COL6a3 on chromosome 2 in primary le-
sions, as well as recurrences and metastases 1,10.
Clinically, patients usually have symptoms 
for many years and the most common com-
plaints are preauricular swelling, pain or limita-
tion of motion 1,2,9,11. Imaging features of TGCT of 
the TMJ consist of a soft tissue mass frequently 
associated with bone erosion with scalloped 
margins and cyst formation as better depicted 
with CT and areas of hyperattenuation due to 
iron deposition 9. On MR, the nodular masses 
usually exhibit low signal intensity on T1- and 
T2-weighted images, reflecting characteristic 
hemosiderin deposition 2,9,11. However the MR 
appearance may vary depending on the propor-
tions of lipid, hemosiderin, fibrous stroma, pan-
nus, fluid, and cellular elements6. MR is sensi-
tive and specific for the diagnosis of TGCT and 
also helps in surgical planning. As in our case, 
avidity on FDG PET/CT has been described 12.
Histopathological features include synovial-
lined spaces, blood-filled pseudoalveolar spaces 
in 10% of the cases, mitotic activity, variable 
cellularity, with small or large histiocyte-like 
cells, osteoclast-like multinucleated giant cells 
and hemosiderin deposits 1,2,13. Giant cells are 
positive for CD68 and CD45, and mononu-
clear cells are positive for CD681. Interestingly 
O’Connell et al. document that 67% of TGCT 
contain dendritic cells expressing S100 protein 
14. A minority of cells are neoplastic and overex-
press CFS 12,13. Cartilaginous and osseous meta-
plasia are rare 13.
In our case there was a mixed immunophe-
notype pattern with histiocyte-like and oste-
oclast-like giant cells positive for CD68, and 
also mononuclear cells in chondroid areas 
positive for S100 protein. This mixed histopa-
thology was previously reported by Oda et 
al. who documented two cases and by Hoch 
et al. 13 who documented five cases of TGCT 
with chondroid metaplasia of the TMJ con-
taining hyaline chondroid nodules and dys-
trophic calcification in chondroid areas, his-
tologically mimicking chondroblastoma. Al-
though TGCT of the TMJ is rare, interestingly 
the TMJ and temporal bone are the most 
common sites of skull chondroblastoma 13.
Chondroblastoma should be in the differen-
tial diagnosis, as imaging features may over-
lap, and the histopathological distinction from 
TGCT may be hard to establish 13. The poten-
tial relationship to chondroblastoma remains 
unclear 13. The differential diagnosis of TGCT 
on MRI also includes synovial chondromato-
sis, tumoral calcium pyrophosphate dihydrate 
crystal deposition disease, rheumatoid arthri-
tis, synovial sarcoma, hemophilia, and syno-
vial hemangioma 2,3,9,13. The occurrence of TGCT 
with synovial chondromatosis is also reported 
in the literature 15, but chondromatosis is char-
acterized by the presence of loose bodies (hya-
line cartilage) with minimal calcification. 
Finally, complete excision with wide margins 
is the treatment of choice 4. Radiation therapy 
may be considered when vital structures are 
involved and to prevent recurrence 4,8. We sug-
gest that MR and PET/CT, when available, 
should be strongly considered in the follow-up 
to monitor tumor recurrence 7.
Conclusion
TGCT of the TMJ with chondroid metapla-
sia is benign but locally destructive. Although 
the definite diagnosis is histological, CT, MR 
and now FDG PET/CT imaging play an impor-
tant role in the preoperative setting, excluding 
other important etiologies and suggesting the 
diagnosis of TGCT if hemosiderin deposition 
is documented. Our case reinforces evidence 
that TGCT with chondroid metaplasia should 
be considered in the differential diagnosis of 
TGCT of the TMJ. The gold standard treatment 
is complete resection with good long-term out-
come. Our case suggests that the best imaging 
to assess a recurrence may be MR and PET/CT.
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